首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >Serum proteome alteration of severe sepsis in the treatment of continuous renal replacement therapy.
【24h】

Serum proteome alteration of severe sepsis in the treatment of continuous renal replacement therapy.

机译:严重脓毒症的血清蛋白质组改变在连续性肾脏替代治疗中的治疗。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Continuous renal replacement therapy (CRRT) techniques have occupied an important position in the intensive care units (ICU). Serum proteome alteration and protein removal in this process are not clear. Since it has a poor understanding of mechanism of the treatment, there is a specific need of proteomics research for CRRT. The aim of this research was to study the serum proteome alterations of severe sepsis patients in the treatment of CRRT. Improved knowledge of proteome alteration could lead to the development of more efficient treatment strategies. METHODS: In this study, 20 severe sepsis patients were enrolled. A proteomic approach with two-dimensional gel electrophoresis (2-DE) coupled with mass spectrometry and bioinformatics methods was utilized to identify proteins with altered expression at different times in the treatment of continuous veno-venous haemofiltration (CVVH). All proteins were identified on the appearance of the 2-DE gel at the appropriate molecular size and pI and score from peptide mass fingerprinting. Protein identifications were confirmed by sequencing of the tryptic peptides and an independent database search based on the sequence. A further validation study was performed by western blot. RESULTS: Thirty-four protein spots expressed differentially were separated. Ten proteins were identified to be the commonly differentially expressed proteins in the treatment. Seven proteins decreased in the serum and three increased. CONCLUSIONS: This study gives a novel overview of serum proteome alteration of severe sepsis patient in the treatment of CVVH. Potentially interesting proteins have been revealed that are different from those identified by method of traditional biology.
机译:背景:连续性肾脏替代治疗(CRRT)技术在重症监护病房(ICU)中占有重要地位。血清蛋白质组改变和蛋白质去除在此过程中尚不清楚。由于对治疗机理了解甚少,因此对CRRT的蛋白质组学研究有特殊的需求。这项研究的目的是研究重症脓毒症患者在CRRT治疗中的血清蛋白质组变化。改善蛋白质组改变的知识可能会导致开发更有效的治疗策略。方法:本研究招募了20名严重败血症患者。蛋白质组学方法与二维凝胶电泳(2-DE)结合质谱法和生物信息学方法一起用于鉴定在连续静脉-静脉血液滤过(CVVH)中在不同时间表达改变的蛋白质。在2-DE凝胶的外观上以适当的分子大小和pI鉴定了所有蛋白质,并从肽质量指纹图中获得了分数。通过对胰蛋白酶肽的测序以及基于该序列的独立数据库搜索来确认蛋白质鉴定。通过蛋白质印迹进行了进一步的验证研究。结果:分离到34个差异表达的蛋白斑点。鉴定出十种蛋白质是治疗中通常差异表达的蛋白质。血清中有7种蛋白质减少而3种增加。结论:本研究为重症脓毒症患者CVVH的血清蛋白质组改变提供了新的综述。已经揭示了潜在的有趣蛋白质,这些蛋白质与通过传统生物学方法鉴定的蛋白质不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号